Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study

Vaccination remains the best strategy to reduce invasive meningococcal disease. This study evaluated an investigational tetanus toxoid-conjugate quadrivalent meningococcal vaccine (MenACYW-TT) vs. a licensed tetanus toxoid-conjugate quadrivalent meningococcal vaccine (MCV4-TT) (NCT02955797). Healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Vliet, D., Vesikari, T., Sandner, B., Martinón-Torres, F., Muzsay, G., Forsten, A., Adelt, T., Diaz Gonzalez, C., Simko, R., B'Chir, S., Neveu, D., Jordanov, E., Dhingra, M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060839/
https://www.ncbi.nlm.nih.gov/pubmed/33541457
http://dx.doi.org/10.1017/S0950268821000261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060839/
https://www.ncbi.nlm.nih.gov/pubmed/33541457
http://dx.doi.org/10.1017/S0950268821000261

Ejemplares similares